NIFTY
187.05  1.60%
 11844.10
S&P BSE SENSEX
623.33  1.61%
 39434.72
Dr. Reddys Laboratories Ltd.
NSE : DRREDDY BSE : 500124 ISIN code : INE089A01023
on 24-May-2019
NSE
26.6    1.01%
Rs. 2663.90
 
Days Low
Rs. 2628.05
Days High
Rs. 2672

Open Rs. 2651
 
52 week Low
Rs. 1934.35
52 week High
Rs.2965.2
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.2664.20
26.8    1.02%
on 24-May-2019
BSE
26.8    1.02%
Rs. 2664.20
 
Days Low
Rs. 2626.2
Days High
Rs. 2673.95

Open Rs. 2650
 
52 week Low
Rs. 1872.95
52 week High
Rs.2964
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.2663.90
26.6    1.01%
 
 
Last Price (Rs.)  2664.20 Value  31930731.00
Net Change (Rs.)  26.80 Best Buy  0.00
Volume  12020 Best Sell  0.00
Prev.Close (Rs.)  2637.40 Best Quantity  0
Open (Rs.)  2651.00 Sell Quantity  0
High (Rs.)  2672.00 52-Week High (Rs.)  2965.20
Low (Rs.)  2628.05 52-Week Low (Rs.)  1934.35
Face Value (Rs.)  5 Market Cap.(Rs/ Mn)  442432.90
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital830.00 829.00 853.00 
Share Capital830.00 829.00 853.00 
Share Capital830.00 829.00 853.00 
Share Capital830.00 829.00 853.00 
Share Capital830.00 829.00 853.00 
Currents Investments16828.00 12991.00 32980.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 415.55 997044 77.46 0.00 0.48
Divis Lab 1762.40 467862 251.75 53.80 0.57
Cipla 570.35 459555 195.87 31.27 0.53
Piramal Enterprises 2198.70 437199 1176.17 76.44 1.27
Aurobindo Pharma 680.90 398950 188.62 22.01 0.37
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2019Dec 2018Sep 2018
Net Sales26452.0027317.0026310.00
Operating Profit5093.007797.006394.00
PBDT5006.007639.006236.00
Net Profit2028.003994.003462.00
More> 
 
Company News
5/21/2019 12:00:00 AM
Dynamic Cables, Panacea Biotec and Dr Reddy's Lab to see some action t...
5/21/2019 12:00:00 AM
Dr Reddy’s Lab trades higher on the bourses
5/20/2019 12:00:00 AM
Dr Reddy’s Lab to spend upto $300 million on R&D in FY20
More>
 
Ratios
   Earnings Per Share (Rs)34.15 
   Book NAV/Share(Rs)706.34 
   PAT Margin (%)6.06 
   Asset Turnover(x)0.56 
   PER(x)60.98 
   Yield(%)0.96 
   EV/Core EBITDA(x)24.15 
   M Cap / Sales3.69 
   Net Sales Growth(%)-3.71 
   PAT Growth(%)-59.04 
   Total Debt/Equity(x)0.22 
   Current Ratio(x)1.91 
   Quick Ratio(x)1.52 
   Total Debt/Mcap(x)0.07 
More>